Access TeleCare Revenue and Competitors

Dallas, VA USA

Location

N/A

Total Funding

Employee Data

  • Access TeleCare has 483 Employees.(i)
  • Access TeleCare grew their employee count by 11% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A6839%N/AN/A
#2
$1.7M52-4%N/AN/A
#3
N/A25213%N/AN/A
#4
N/A4137%N/AN/A
#5
N/A2433%N/AN/A
#6
N/A8264%N/AN/A
#7
N/A3135%N/AN/A
#8
N/A574%N/AN/A
#9
$35M1110%N/AN/A
#10
N/A950%N/AN/A
Add Company

What Is Access TeleCare?

Access TeleCare (previously SOC Telemed) is the leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. Built on proven and scalable infrastructure as an enterprise-wide solution, Access TeleCare’s technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. Access TeleCare provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry, teleCritical Care, telePulmonology, teleCardiology, teleInfectious Disease, teleNephrology, teleMaternal Fetal Medicine and other service lines, enabling healthcare organizations to build sustainable telemedicine programs across clinical specialties. Access TeleCare enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission’s Gold Seal of Approval and has maintained that accreditation every year since inception. For more information, visit www.soctelemed.com.

keywords:N/A

N/A

Total Funding

483

Number of Employees

N/A

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$87M48946%$560M
#2
$134.8M490-3%N/A
#3
$178M49143%N/A
#4
$129.7M494N/AN/A
#5
$129.7M4945%N/A